We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Assessment of the efficacy of topical antiandrogen; spironolactone in patients with androgenetic alopecia by dermoscopy.
- Authors
Soliman, Ahmed M.; Hussein, Sherief Mahdy; El-Alim, Sameh Hosam Abd; Kassem, Ahmed Alaa; Emam, Hanaa; Shehata, Hany; Rabie, Ahmad Abdelmaksood; Aly, Hanan Farouk; El Zawahry, Yasmin Bakr
- Abstract
Background Androgenetic Alopecia (AGA) is a non-scarring alopecia characterized by progressive miniaturization of hair follicles with a distinctive distribution in genetically prone males & females. Topical Spironolactone is commonly used as off-label anti-androgen for managment of AGA. Objective Assessing role of topical 1% spironolactone on hair thickness & count in patients with AGA using dermoscopy. Methods 26 patients (16 males and 10 females) with ages ranging from 26 to 59 years with a mean±SD of 42.77±6.62 received topical 1% spironolactone solution to apply on the scalp once daily for at least six months. All patients had positive family history. Dermoscopy was performed on fixed areas on the scalp. Images were taken with a digital camera that was connected to the dermoscope just before starting treatment and after 6 months continuous treatment. Results Significant increase in total terminal, terminal thick and total hair count in female patients along with a significant increase in total terminal, terminal thin, vellus and total hair count in male ones after treatment with topical 1% spironolactone were seen. However, thin and vellus hair in female and thick hair in male revealed no significant difference post spironolactone treatment. Conclusion Spironolactone is an effective & harmless treatment in both females & males with AGA.
- Subjects
DERMOSCOPY; SPIRONOLACTONE; BALDNESS; HAIR follicles; DIGITAL cameras
- Publication
Journal of Pakistan Association of Dermatologists, 2022, Vol 32, Issue 3, p493
- ISSN
1560-9014
- Publication type
Article